Cargando…
Antipsychotics for negative and positive symptoms of schizophrenia: dose-response meta-analysis of randomized controlled acute phase trials
Determining the optimal antipsychotic target dose in acute phase treatment is of high clinical relevance. The effect of antipsychotics on negative symptoms should be taken into account because patients will often continue on the treatment received in the acute phase. Therefore, we conducted a formal...
Autores principales: | Sabe, Michel, Zhao, Nan, Crippa, Alessio, Kaiser, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438046/ https://www.ncbi.nlm.nih.gov/pubmed/34518532 http://dx.doi.org/10.1038/s41537-021-00171-2 |
Ejemplares similares
-
Intranasal Oxytocin for Negative Symptoms of Schizophrenia: Systematic Review, Meta-Analysis, and Dose-Response Meta-Analysis of Randomized Controlled Trials
por: Sabe, Michel, et al.
Publicado: (2021) -
O7.3. DOSE-RESPONSE META-ANALYSIS TO IDENTIFY THE OPTIMUM AND EQUIVALENT DOSES OF ANTIPSYCHOTIC DRUGS FOR SCHIZOPHRENIA
por: Leucht, Stefan, et al.
Publicado: (2018) -
Adding antidepressants to antipsychotics for treatment of subsyndromal depressive symptoms in schizophrenia: Impact on positive and negative symptoms
por: Vahia, Ipsit V., et al.
Publicado: (2013) -
EPA guidance on treatment of negative symptoms in schizophrenia
por: Galderisi, S., et al.
Publicado: (2021) -
EPA guidance on assessment of negative symptoms in schizophrenia
por: Galderisi, S., et al.
Publicado: (2021)